Atlas Trials

Vaginal Cancer

77 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Vaginal Cancer

RecordFirmDate
Gynaecology Exercise and Mindfulness Study (NCT05561413)University of Ulster2022-06-14
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine (NCT05371353)Shanghai Bovax Biotechnology Co., Ltd.2022-05-14
Retrospective Study of Brachytherapy (NCT05242861)Zhejiang Cancer Hospital2022-02-20
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers (NCT04708470)National Cancer Institute (NCI)2021-10-05
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years (NCT05027776)Shanghai Bovax Biotechnology Co., Ltd.2021-09-15
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years (NCT04895020)Shanghai Bovax Biotechnology Co., Ltd.2021-05-28
The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479)Taproot Health2021-05-05
Relational Agents in Cervical Cancer Education (RACE) (NCT06537687)Radhika Gogoi2020-11-18
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT05372016)Shanghai Bovax Biotechnology Co., Ltd.2020-09-19
Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation (NCT04626466)Institut de cancérologie Strasbourg Europe2020-08-03
Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04425291)Shanghai Bovax Biotechnology Co., Ltd.2020-05-28
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04422366)Shanghai Bovax Biotechnology Co., Ltd.2020-04-28
Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy (NCT03956498)Institut Claudius Regaud2019-10-09
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT03676101)Shanghai Bovax Biotechnology Co., Ltd.2018-10-10
Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer (NCT03611517)Leiden University Medical Center2018-08-07
Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) (NCT03158220)Merck Sharp & Dohme LLC2017-09-20
Image-Guided Gynecologic Brachytherapy (NCT02993900)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2016-12-15
MR-HIFU for Recurrent Gynaecological Cancer (NCT02714621)Institute of Cancer Research, United Kingdom2016-05-01
Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) (NCT02653118)Merck Sharp & Dohme LLC2016-01-22
Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer (NCT02458001)University College, London2015-07-01
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers (NCT02280811)National Cancer Institute (NCI)2014-10-14
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer (NCT02096783)University of Wisconsin, Madison2014-09-01
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy (NCT02058550)Stanford University2014-09-01
Integrated Cancer Repository for Cancer Research (NCT02012699)University of Nebraska2013-11-01
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers (NCT01585428)National Cancer Institute (NCI)2012-04-13
Image-Guided Gynecologic Brachytherapy (NCT01399658)Dana-Farber Cancer Institute2011-09-01
A Survivorship Care Plan for Gynaecological Cancer Patients (NCT01582906)Royal Marsden NHS Foundation Trust2011-08-01
Validation of a Nutrition Screening Tool (NCT01851928)Royal Marsden NHS Foundation Trust2011-07-01
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer (NCT01216813)Royal Marsden NHS Foundation Trust2010-08-01
Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer (NCT01097239)Imperial College London2009-11-01
A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) (NCT00943722)Merck Sharp & Dohme LLC2009-08-27
Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema (NCT00944944)Memorial Sloan Kettering Cancer Center2009-07-01
Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life (NCT00870233)Memorial Sloan Kettering Cancer Center2009-03-24
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer (NCT01087268)Royal Marsden NHS Foundation Trust2009-01-01
Pelvic Fractures and Radiation Therapy for Cervical Cancer (NCT00800644)M.D. Anderson Cancer Center2008-11-05
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer (NCT00905658)Centre Oscar Lambret2008-06-01
A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) (NCT00551187)Merck Sharp & Dohme LLC2007-10-01
Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) (NCT00520598)Merck Sharp & Dohme LLC2007-10-01
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) (NCT00543543)Merck Sharp & Dohme LLC2007-09-24
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers (NCT00545792)Dana-Farber Cancer Institute2007-05-01
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer (NCT00381888)Masonic Cancer Center, University of Minnesota2007-01-01
ChemoFx® PRO - A Post-Market Data Collection Study (NCT00669422)Precision Therapeutics2006-10-01
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance (NCT00581646)Memorial Sloan Kettering Cancer Center2006-09-01
Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) (NCT00851643)Merck Sharp & Dohme LLC2006-04-01
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer (NCT00601406)The Christie NHS Foundation Trust2006-03-01
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer (NCT00287885)Masonic Cancer Center, University of Minnesota2004-03-01
Internet-based System for Cancer Patients to Self-report Toxicity (NCT00578006)Memorial Sloan Kettering Cancer Center2004-03-01
Effectiveness of an Individualized Symptom Education Program (ISEP) (NCT00275353)University of Toronto2003-07-01
Lymphoscintigraphy in Patients With Vaginal Cancer (NCT00528034)M.D. Anderson Cancer Center2002-09-01
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis (NCT00033605)Alliance for Clinical Trials in Oncology2002-04-01
Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function (NCT00588081)Memorial Sloan Kettering Cancer Center2001-05-01
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention (NCT00005095)Northwestern University2000-03-01
Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer (NCT00005941)Fred Hutchinson Cancer Center1999-11-01
Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer (NCT00003267)European Organisation for Research and Treatment of Cancer - EORTC1998-02-01
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis (NCT00002949)University of Chicago1996-07-01
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer (NCT00002562)Gynecologic Oncology Group1994-03-01

Track Vaginal Cancer automatically

Every clearance here is in the API, with alerts when new ones post.